ENDRA LIFE SCIENCES INC. Current Foreign Tax Expense (Benefit)
ENDRA LIFE SCIENCES INC. (NDRA) reported Current Foreign Tax Expense (Benefit) of $0 for the 12-month period ending 2024-12-31, per its 10-K/A filed 2025-04-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentForeignTaxExpenseBenefit · last filed 2025-04-07
- ENDRA LIFE SCIENCES INC. current foreign tax expense (benefit) for fiscal 2024 was $0.00.
- ENDRA LIFE SCIENCES INC. current foreign tax expense (benefit) for fiscal 2023 was $0.00.
- ENDRA LIFE SCIENCES INC. current foreign tax expense (benefit) for fiscal 2022 was $0.00.
- ENDRA LIFE SCIENCES INC. current foreign tax expense (benefit) for fiscal 2021 was $0.00.
| Period end | Current Foreign Tax Expense (Benefit) 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K/A · filed 2025-04-07 |
| 2023-12-31 | $0.00 10-K/A · filed 2025-04-07 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |